WHO Working On ‘Evolved’ Model For COVID-19 Licensing Platform

 
• By Ian Schofield

With companies still reluctant to share their IP and knowledge via the C-TAP platform, stakeholders will be offered the chance to comment on a proposed new model that is expected to cover drugs for other high-priority diseases.

PS1805_Teamwork_383615959_1200.jpg
A shared effort is needed to tackle COVID-19 and other high-priority diseases • Source: Shutterstock

More from International

More from Geography